219 related articles for article (PubMed ID: 27336601)
1. Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study.
Mosconi C; Gramenzi A; Ascanio S; Cappelli A; Renzulli M; Pettinato C; Brandi G; Monari F; Cucchetti A; Trevisani F; Golfieri R
Br J Cancer; 2016 Jul; 115(3):297-302. PubMed ID: 27336601
[TBL] [Abstract][Full Text] [Related]
2. Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.
Camacho JC; Kokabi N; Xing M; Prajapati HJ; El-Rayes B; Kim HS
J Vasc Interv Radiol; 2014 Feb; 25(2):256-65. PubMed ID: 24461131
[TBL] [Abstract][Full Text] [Related]
3. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
Hoffmann RT; Paprottka PM; Schön A; Bamberg F; Haug A; Dürr EM; Rauch B; Trumm CT; Jakobs TF; Helmberger TK; Reiser MF; Kolligs FT
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):105-16. PubMed ID: 21431970
[TBL] [Abstract][Full Text] [Related]
4. Yttrium-90 Transarterial Radioembolization for Chemotherapy-Refractory Intrahepatic Cholangiocarcinoma: A Prospective, Observational Study.
White J; Carolan-Rees G; Dale M; Patrick HE; See TC; Bell JK; Manas DM; Crellin A; Slevin NJ; Sharma RA
J Vasc Interv Radiol; 2019 Aug; 30(8):1185-1192. PubMed ID: 31255499
[TBL] [Abstract][Full Text] [Related]
5. Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma.
Mosconi C; Cappelli A; Ascanio S; Pettinari I; Modestino F; Renzulli M; Galaverni MC; Cucchetti A; Gramenzi A; Pettinato C; Golfieri R
Future Oncol; 2017 Jun; 13(15):1301-1310. PubMed ID: 28343412
[TBL] [Abstract][Full Text] [Related]
6. Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option.
Saxena A; Bester L; Chua TC; Chu FC; Morris DL
Ann Surg Oncol; 2010 Feb; 17(2):484-91. PubMed ID: 19876691
[TBL] [Abstract][Full Text] [Related]
7. Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study.
Gangi A; Shah J; Hatfield N; Smith J; Sweeney J; Choi J; El-Haddad G; Biebel B; Parikh N; Arslan B; Hoffe SE; Frakes JM; Springett GM; Anaya DA; Malafa M; Chen DT; Chen Y; Kim RD; Shridhar R; Kis B
J Vasc Interv Radiol; 2018 Aug; 29(8):1101-1108. PubMed ID: 30042074
[TBL] [Abstract][Full Text] [Related]
8. Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.
Mouli S; Memon K; Baker T; Benson AB; Mulcahy MF; Gupta R; Ryu RK; Salem R; Lewandowski RJ
J Vasc Interv Radiol; 2013 Aug; 24(8):1227-34. PubMed ID: 23602420
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors in Overall Survival of Patients with Unresectable Intrahepatic Cholangiocarcinoma Treated by Means of Yttrium-90 Radioembolization: Results in Therapy-Naïve Patients.
Reimer P; Virarkar MK; Binnenhei M; Justinger M; Schön MR; Tatsch K
Cardiovasc Intervent Radiol; 2018 May; 41(5):744-752. PubMed ID: 29344713
[TBL] [Abstract][Full Text] [Related]
10. Update of the Bologna Experience in Radioembolization of Intrahepatic cholangiocarcinoma.
Mosconi C; Cacioppa LM; Cappelli A; Gramenzi AG; Vara G; Modestino F; Renzulli M; Golfieri R
Technol Cancer Res Treat; 2023; 22():15330338231155690. PubMed ID: 36927302
[TBL] [Abstract][Full Text] [Related]
11. Resin-based Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic cholangiocarcinoma: preliminary results.
Jia Z; Paz-Fumagalli R; Frey G; Sella DM; McKinney JM; Wang W
J Cancer Res Clin Oncol; 2017 Mar; 143(3):481-489. PubMed ID: 27826686
[TBL] [Abstract][Full Text] [Related]
12. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
Ibrahim SM; Mulcahy MF; Lewandowski RJ; Sato KT; Ryu RK; Masterson EJ; Newman SB; Benson A; Omary RA; Salem R
Cancer; 2008 Oct; 113(8):2119-28. PubMed ID: 18759346
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Choi criteria and Response Evaluation Criteria in Solid Tumors (RECIST) for intrahepatic cholangiocarcinoma treated with glass-microspheres Yttrium-90 selective internal radiation therapy (SIRT).
Beuzit L; Edeline J; Brun V; Ronot M; Guillygomarc'h A; Boudjema K; Gandon Y; Garin E; Rolland Y
Eur J Radiol; 2016 Aug; 85(8):1445-52. PubMed ID: 27423686
[TBL] [Abstract][Full Text] [Related]
14. Factors Impacting Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: A Combined Analysis of the Prospective CIRT Studies.
Reimer P; Vilgrain V; Arnold D; Balli T; Golfieri R; Loffroy R; Mosconi C; Ronot M; Sengel C; Schaefer N; Maleux G; Munneke G; Peynircioglu B; Sangro B; Kaufmann N; Urdaniz M; Pereira H; de Jong N; Helmberger T
Cardiovasc Intervent Radiol; 2024 Mar; 47(3):310-324. PubMed ID: 38321223
[TBL] [Abstract][Full Text] [Related]
15. Yttrium-90 Radioembolization in Intrahepatic Cholangiocarcinoma: A Multicenter Retrospective Analysis.
Buettner S; Braat AJAT; Margonis GA; Brown DB; Taylor KB; Borgmann AJ; Kappadath SC; Mahvash A; IJzermans JNM; Weiss MJ; Lamarca A; Bell JK; Valle JW; Hagendoorn J; Koerkamp BG; Sze DY; Lam MGEH
J Vasc Interv Radiol; 2020 Jul; 31(7):1035-1043.e2. PubMed ID: 32473757
[TBL] [Abstract][Full Text] [Related]
16. Yttrium-90 Radioembolization in Unresectable Intrahepatic Cholangiocarcinoma: Results of a Multicenter Retrospective Study.
Bargellini I; Mosconi C; Pizzi G; Lorenzoni G; Vivaldi C; Cappelli A; Vallati GE; Boni G; Cappelli F; Paladini A; Sciuto R; Masi G; Golfieri R; Cioni R
Cardiovasc Intervent Radiol; 2020 Sep; 43(9):1305-1314. PubMed ID: 32642986
[TBL] [Abstract][Full Text] [Related]
17. PET response criteria for solid tumors predict survival at three months after intra-arterial resin-based 90Yttrium radioembolization therapy for unresectable intrahepatic cholangiocarcinoma.
Camacho JC; Kokabi N; Xing M; Schuster DM; Kim HS
Clin Nucl Med; 2014 Nov; 39(11):944-50. PubMed ID: 25140563
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Yttrium-90 Radioembolization for Unresectable Combined Biphenotypic Hepatocellular-Cholangiocarcinoma.
Malone CD; Gibby W; Tsai R; Kim SK; Lancia S; Akinwande O; Ramaswamy RS
J Vasc Interv Radiol; 2020 May; 31(5):701-709. PubMed ID: 32127318
[TBL] [Abstract][Full Text] [Related]
19. Change in total lesion glycolysis and clinical outcome after (90)Y radioembolization in intrahepatic cholangiocarcinoma.
Filippi L; Pelle G; Cianni R; Scopinaro F; Bagni O
Nucl Med Biol; 2015 Jan; 42(1):59-64. PubMed ID: 25213104
[TBL] [Abstract][Full Text] [Related]
20. Radioembolization with Yttrium-90 Glass Microspheres as a First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma-A Prospective Feasibility Study.
Kis B; Shridhar R; Mhaskar R; Gyano M; Frakes JM; El-Haddad G; Choi J; Kim RD; Hoffe SE
J Vasc Interv Radiol; 2023 Sep; 34(9):1547-1555. PubMed ID: 37210030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
